Newly Approved Drug Therapies (327): FLOMAX, Boehringer Ingelheim

Description of Medical Areas

About the FDA Approved Listings

Drugs Approved by the FDA

Drug Name: FLOMAX

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Boehringer Ingelheim
Approval Status: Approved October 1997
Treatment for: benign prostatic hypertrophy (BPH)

General Information

FLOMAX has been approved for the treatment of benign prostatic hypertrophy (BPH). Boehringer Ingelheim, which licensed the product from originator Yamanouchi, will market the product in the U.S.

Back to Drug Listing

Drug listing last updated on June 20, 2008

Patient Resources: [ Trial Listing ] [ Notification Services ] [ Drug Directories ]
[ About Clinical Research ] [ Patient Resources ] [ Patient Bookstore ]
Professional Resources: [ Research Center Profiles ] [ Industry Provider Profiles ] [ Jobs in Clinical Research ]
[ Industry News ] [ Professional Resources ] [ Professional Bookstore ]
General: [ Search ] [ Site Map ] [ Your Privacy ] [ CW World ] [ Home ]